GPTHEALTH2023-10-012023-12-31 GPTHEALTH2023-10-012023-12-31 GPTHEALTH2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member GPTHEALTH2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member GPTHEALTH2023-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544131 GPTHEALTH NOTLISTED GPT Healthcare Limited Equity 2023-04-01 2024-03-31 2024-03-19 2024-03-11 INR Lakhs Third quarter 14:30:00 15:30:00 2024-03-19 2024-03-19 Not applicable Single segment Healthcare Services 2023-10-01 2023-12-31 Unaudited Standalone 965917000.00 11782000.00 977699000.00 196956000.00 0.00 0.00 172621000.00 16905000.00 45011000.00 386331000.00 817824000.00 159875000.00 0.00 159875000.00 28200000.00 16975000.00 45175000.00 0.00 114700000.00 0.00 0.00 0.00 0.00 114700000.00 -708000.00 113992000.00 0.00 0.00 79904000.00 10 1.44 1.44 0.00 0.00 1.44 1.44 Notes: 1 This statement have been prepared in accordance with the recognition and measurements principles as laid down in Indian Accounting Standard ( Ind AS ) 34 - Interim Financial Reporting prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2 The above unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on March 19, 2024. The said results have subject to limited review by the statutory auditors of the company for the quarter and nine months December 31, 2023. The financial results for the quarter and nine months ended December 31, 2022 and for the quarter ended September 30, 2023 have not been reviewed / audited by the statutory auditors. The management has exercised necessary diligence to ensure that the financial results for the periods provide a true and fair view of the Company's affairs. 3 GPT Healthcare Limited ( the Company ) has completed Initial Public Offering (IPO) comprising of fresh issue of 21,50,537 equity shares and offer for sale from investor selling shareholder of 2,60,82,786 equity shares of face value `10 each at an issue price of `186 per share for cash consideration aggregating to `525.14 Crores, subsequent to quarter ended December 31, 2023. Pursuant to IPO, equity shares of the Company were listed on BSE Limited and National Stock Exchange w.e.f. February 29, 2024. The above statement of unaudited financial results for the quarter and nine months ended December 31, 2023 are drawn up in accordance with the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. 4 The company operates in one single reportable business segment and geographical segment i.e. healthcare service in India. 5 The Board of Directors of the Company have declared a second Interim Dividend @ 10% i.e. `1 per Equity Share. The record date for payment of second interim dividend has been fixed as April 1, 2024. Total dividend for the financial year 2023-24 is `2 per Equity share on the face value of `10 per share. 6 The above unaudited financial results are also available on the Company's website www.ilshospitals.com and also on the stock exchange websites (www.bseindia.com and www.nseindia.com). Single segment 2023-04-01 2023-12-31 Unaudited Standalone 3007673000.00 36992000.00 3044665000.00 621742000.00 0.00 0.00 519372000.00 55110000.00 132232000.00 1219918000.00 2548374000.00 496291000.00 0.00 496291000.00 86900000.00 59864000.00 146764000.00 0.00 349527000.00 0.00 0.00 0.00 0.00 349527000.00 -2853000.00 346674000.00 0.00 0.00 79904000.00 10 4.37 4.37 0.00 0.00 4.37 4.37 Other expenses 386331000.00 Other expenses 1219918000.00 -1000000.00 -4027000.00 -292000.00 -1174000.00 0.00 0.00